2 Histopathological classification phenotype and molecular pathology of lung tumors

Handbook of Immunohistochemistry and in Situ Hybridization of Human Carcinomas

Volumn 1, Issue , 2002, Pages 105-114

  Brambilla, Elisabeth ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67649354426     PISSN: 18745784     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1874-5784(04)80021-7     Document Type: Chapter

References (27)

1. Brambilla E., Moro D., Gazzeri S., Morel P., Jacrot M., and Brambilla C. Cytotoxic chemotherapy induces cell differentiation in small cell lung carcinoma. J. Clin. Oncol. 9 (1991) 50-61
2. Brambilla E., Moro D., Veale D., Brichon P.Y., Stoebner P., Paramelle B., and Brambilla C. Basal cell (basaloid) carcinoma of the lung: A new morphologic and phenotypic entity with separate prognostic significance. Hum. Pathol. 25 (1992) 993-1003
3. Chan J.K., Hui P.K., Tsang W.Y., Law C.K., Ma C.C., Yip T.T., and Poon Y.F. Primary lymphoepithelioma-like carcinoma of the lung: A clinicopathologic study of 11 cases. Cancer 76 (1995) 413-422
4. Fishback N.F., Travis W.D., Moran C.A., Guinee Jr. D.G., McCarthy W.F., and Koss M.N. Pleomorphic (spindle/giant cell) carcinoma of the lung: A clinicopathologic correlation of 78 cases. Cancer 73 (1994) 2936-2945
5. Gazzeri S., Delia Valle V., Chaussde L., Brambilla C., Larsen C.J., and Brambilla E. The human p19ARF protein encoded by the b transcript of the p16INK4 gene is frequently lost in small cell lung tumors. Cancer Res. 58 (1998) 3926-3931
6. Gazzeri S., Gouyer V., Vour'ch C., Brambilla C., and Brambilla E. Mechanism of p16INK4A inactivation in non-small-cell lung cancers. Oncogene 16 (1998) 497-505
7. Greenlee R.T., Hill-Harmon M.B., Murray T., and Thun M. Cancer Statistics, 2001. CA Cancer J. Clin. 51 (2001) 15-36
8. author reply 555-556. Hainaut P., Olivier M., and Pfeifer G.P. TP53 mutation spectrum in lung cancers and mutagenic signature of components of tobacco smoke: Lessons from the IARC TP53 mutation database. Mutagenesis 16 6 (2001) 551-553
9. Lantuejoul S., Moro D., Michalides R.J., Brambilla C., and Brambilla E. Neural cell adhesion molecules (NCAM) and NCAM-PSA expression in neuroendocrine lung tumors. Am. J. Surg. Pathol. 22 (1998) 1267-1276
10. Moro D., Brichon P.Y., Brambilla E., Veale D., Labat-Moleur F., and Brambilla C. Basaloid bronchial carcinoma: A histological group with a poor prognosis. Cancer 75 (1994) 2734-2739
11. Naylor S.L., Johnson B.E., Minna J.D., and Sakaguchi A.Y. Loss of heterozygosity of chromosome 3p markers in small-cell lung cancer. Nature 329 (1987) 451-454
12. Nicholson S.A., Beasley M.B., Brambilla E., Hasleton P.S., Colby T.V., Sheppard M.N., Falk R., and Travis W.D. Small cell lung carcinoma (SCLC): A clinicopathologic study of 100 cases. Am. J. Surg. Pathol 26 9 (2002) 1184-1197
13. Noguchi M., Morikawa A., Kawasaki M., Matsuno Y., Yamada T., Hirohashi S., Kondo H., and Shimosato Y. Small adenocarcinoma of the lung. Histologic characteristics and prognosis. Cancer 75 (1995) 2844-2852
14. Ordonnez N. Value of thyroid transcription factor-1 immunostaining in distinguishing small cell lung carcinomas from other small cell carcinomas. Am. J. Surg. Pathol. 24 (2000) 1217-1223
15. Rossi G., Cavazza A., Sturm N., Migaldi M., Facciolongo N., Longo L., Maiorana A., and Brambilla E. Pulmonary carcinomas with pleomorphic, sarcomatoid or sarcomatous elements: A clinicopathologic and immunohistochemical study of 75 cases. Am. J. Surgical Pathol. 27 3 (2003) 311-324
16. in press. Rossi G., Murer B., Cavazza A., Losi L., Natalpi P., Marchioni A., Migaldi M., Capitanio G., and Brambilla E. Primary mucinous (so-called coloid) carcinomas of the lung: A clinicopathologic and immunohistochemical study with special reference to CDX-2 homeobox gene an. Am. J. Surg. Pathol. (2004)
17. Sehested M., Hirsch F.R., Osterlind K., and Olsen J.E. Morphologic variations of small cell lung cancer: A histopathologic study of pretreatment and posttreatment specimens in 104 patients. Cancer 57 (1986) 804-807
18. Sozzi G., Veronese M.L., Negrini M., Baffa R., Cotticelli M.G., Inoue H., Tornielli S., Pilotti S., De Gregorio L., Pastorino U., Pierotti M.A., Ohta M., Huebner K., and Croce CM. The FHIT gene at 3p142 is abnormal in lung cancer. Cell 85 (1996) 17-26
19. Sturm N., Lantuejoul S., Laverriere M.H., Papotti M., Brichon P.Y., Brambilla C., and Brambilla E. Thyroid transcription factor-1 (TTF-1) and cytokeratin 1, 5, 10, 14 (34betaE12) expression in basaloid and large cell neuroendocrine carcinomas of the lung. Hum. Pathol. 32 9 (2001) 918-925
20. Sturm N., Rossi G., Lantuejoul S., Papotti M., Frachon S., Claraz C., Brichon P.Y., Brambilla C., and Brambilla E. Expression of thyroid transcription factor-1 (TTF-1) in the spectrum of neuroendocrine cell lung proliferations with special interest in carcinoids. Human Pathol. 33 2 (2002) 175-182
21. Suzuki K., Yokose T., Yoshida J., Nishimura M., Takahashi K., Nagai K., and Nishiwaki K. Prognostic significance of the size of central fibrosis in peripheral adenocarcinoma of the lung. Ann. Thorac. Surg. 69 (2000) 893-897
22. Toyooka S., Toyooka K.O., Maruyama R., Virmani A.K., Girard L., Miyajima K., Harada K., Ariyoshi Y., Takahashi T., Sugio K., Brambilla E., Gilcrease M., Minna J.D., and Gazdar A.F. DNA methylation profiles of lung tumors. Mol. Cancer Therapeut. 1 1 (2001) 61-67
23. Travis W.D., Linnoila R.I., Tsokos M.G., Hitchcock C.L., Cutler Jr. G.B., Nieman L., Chrousos G., Pass H., and Doppman J. Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma: An ultrastructural, immunohistochemical, and flow cytometric. Am. J. Surg. Pathol. 15 (1991) 529-553
24. Travis W.D., Lubin J., Ries L., and Devesa S. United States lung carcinoma incidence trends: Declining for most histologic types among males, increasing among females. Cancer 77 (1996) 2464-2470
25. Travis W.D., Rush W., Flieder D.B., Falk R., Fleming M.V., Gal A.A., and Koss M.N. Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid. Am. J. Surg. Pathol 22 (1998) 934-944
26. Travis W.D., Colby T.V., Corrin B., Shimosato Y., and Brambilla E. Histological Typing of Lung and Pleural Tumors (1999), Springer, Berlin
27. Yokose T., Suzuki K., Nagai K., Nishiwaki Y., Sasaki S., and Ochiai A. Favorable and unfavorable morphological prognostic factors in peripheral adenocarcinoma of the lung 3 cm or less in diameter [In Process Citation]. Lung Cancer 29 (2000) 179-188